ALLENDALE, NJ—Allendale, NJ-based PCT, a cell therapy development and manufacturing company, is expanding its facilities to include additional clean rooms and other upgrades, to improve the firm's ability to provide meet compliance requirements for product distribution into the European Union.
Poskanzer Skott Architects, based in nearby Ridgewood, NJ, designed the expansion facilities for PCT.
“The expanded design provides additional space to house growing demand for our services, including expanding our capability to process, manufacture and develop EU-compliant cell therapy products,” says Robert A. Preti, PhD, president and co-founder of PCT. “We thank PSA for their past and ongoing support to grow PCT's infrastructure alongside the advancement of the cell therapy industry.”
PSA designed the original Allendale facility in 2008, with plans to build out in phases. Phase One included four clean room suites and a freezer farm unit with multiple liquid nitrogen freezers. PSA subsequently designed two additional clean rooms which were done in 2016. Recently completed stages of the work include redesigned warehouse and storage space with plans to move and upgrade bathrooms and locker rooms. The two additional clean rooms included in this new design will bring the facility up to a total of eight which are fully compliant with Food and Drug Administration norms and five which are compliant with requirements set by the European Medicines Agency. PCT expects construction on the latest expansion to be completed in 2017. The standards, known as Current Good Manufacturing Practices, or CGMPs, provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities.
“We take great pride in the quality and longevity of our relationship with PCT,” says partner Barry Poszkanzer, AIA. “PCT is an exciting company and we look forward to providing additional support and services as the company expands, and as compliance regulations require.”
PCT is the only GMP-compliant cell therapy external manufacturing partner with two facilities located on both east and west coasts of the United States. Its CGMP infrastructure for the manufacturing of cell-therapy based products including: quality systems, streamlined technology, transfer, storage, logistics, cell and tissue processing.
ALLENDALE, NJ—Allendale, NJ-based PCT, a cell therapy development and manufacturing company, is expanding its facilities to include additional clean rooms and other upgrades, to improve the firm's ability to provide meet compliance requirements for product distribution into the European Union.
Poskanzer Skott Architects, based in nearby Ridgewood, NJ, designed the expansion facilities for PCT.
“The expanded design provides additional space to house growing demand for our services, including expanding our capability to process, manufacture and develop EU-compliant cell therapy products,” says Robert A. Preti, PhD, president and co-founder of PCT. “We thank PSA for their past and ongoing support to grow PCT's infrastructure alongside the advancement of the cell therapy industry.”
PSA designed the original Allendale facility in 2008, with plans to build out in phases. Phase One included four clean room suites and a freezer farm unit with multiple liquid nitrogen freezers. PSA subsequently designed two additional clean rooms which were done in 2016. Recently completed stages of the work include redesigned warehouse and storage space with plans to move and upgrade bathrooms and locker rooms. The two additional clean rooms included in this new design will bring the facility up to a total of eight which are fully compliant with Food and Drug Administration norms and five which are compliant with requirements set by the European Medicines Agency. PCT expects construction on the latest expansion to be completed in 2017. The standards, known as Current Good Manufacturing Practices, or CGMPs, provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities.
“We take great pride in the quality and longevity of our relationship with PCT,” says partner Barry Poszkanzer, AIA. “PCT is an exciting company and we look forward to providing additional support and services as the company expands, and as compliance regulations require.”
PCT is the only GMP-compliant cell therapy external manufacturing partner with two facilities located on both east and west coasts of the United States. Its CGMP infrastructure for the manufacturing of cell-therapy based products including: quality systems, streamlined technology, transfer, storage, logistics, cell and tissue processing.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Steve Lubetkin
Steve Lubetkin is the New Jersey and Philadelphia editor for GlobeSt.com. He is currently filling in covering Chicago and Midwest markets until a new permanent editor is named. He previously filled in covering Atlanta. Steve’s journalism background includes print and broadcast reporting for NJ news organizations. His audio and video work for GlobeSt.com has been honored by the Garden State Journalists Association, and he has also been recognized for video by the New Jersey Chapter of the Society of Professional Journalists. He has produced audio podcasts on CRE topics for the NAR Commercial Division and the CCIM Institute. Steve has also served (from August 2017 to March 2018) as national broadcast news correspondent for CEOReport.com, a news website focused on practical advice for senior executives in small- and medium-sized companies. Steve also reports on-camera and covers conferences for NJSpotlight.com, a public policy news coverage website focused on New Jersey government and industry; and for clients of StateBroadcastNews.com, a division of The Lubetkin Media Companies LLC. Steve has been the computer columnist for the Jewish Community Voice of Southern New Jersey, since 1996. Steve is co-author, with Toronto-based podcasting pioneer Donna Papacosta, of the book, The Business of Podcasting: How to Take Your Podcasting Passion from the Personal to the Professional. You can email Steve at [email protected].
